Detection of an Underlying 22q11.2 Duplication in a Female Neonate With Trisomy 18

Donald E. Turbiville, Hai Wu, Jianli Dong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Current guidelines indicate that in patients with developmental disabilities or congenital anomalies, chromosomal microarray (CMA) is a first-tier diagnostic test. However, for patients with obvious chromosomal syndromes such as trisomy 13, 18, and 21, G-banded karyotyping is still recommended over CMA for establishing a diagnosis. In the case presented herein, a female neonate was suspected of having trisomy 18 based on pre- and postnatal evaluations. Karyotyping was requested but not performed due to insufficient cell growth; Interphase fluorescence in situ hybridization (i-FISH) found an extra copy of chromosome 18. CMA analysis uncovered gain of chromosome 18 and an additional duplication in chromosome 22q11.2, which went undetected with FISH. Our patient died within 40 hours after birth, but it is expected that patients with recognizable chromosomal syndromes could benefit from the discovery of coexisting copy number variations (CNVs) using CMA. This case shows that CMA can be a useful test for patients with recognizable chromosomal syndromes because of the potential benefits for patients and their families when co-existing CNVs are found.

Original languageEnglish (US)
Pages (from-to)372-375
Number of pages4
JournalLaboratory Medicine
Volume48
Issue number4
DOIs
StatePublished - Nov 8 2017

Fingerprint

Microarrays
Newborn Infant
Chromosomes
Chromosomes, Human, Pair 18
Karyotyping
Chromosome Duplication
Cell growth
Developmental Disabilities
Interphase
Microarray Analysis
Down Syndrome
Fluorescence In Situ Hybridization
Routine Diagnostic Tests
Fluorescence
Chromosome 22q11.2 Microduplication Syndrome
Trisomy 18
Parturition
Guidelines
Growth

Keywords

  • 22q11.2 duplication syndrome
  • CNV
  • copy number variation
  • trisomy 18
  • whole genome chromosomal microarray

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Detection of an Underlying 22q11.2 Duplication in a Female Neonate With Trisomy 18. / Turbiville, Donald E.; Wu, Hai; Dong, Jianli.

In: Laboratory Medicine, Vol. 48, No. 4, 08.11.2017, p. 372-375.

Research output: Contribution to journalArticle

Turbiville, Donald E. ; Wu, Hai ; Dong, Jianli. / Detection of an Underlying 22q11.2 Duplication in a Female Neonate With Trisomy 18. In: Laboratory Medicine. 2017 ; Vol. 48, No. 4. pp. 372-375.
@article{dedbae7dee6e48b2832e9f9d0a805f91,
title = "Detection of an Underlying 22q11.2 Duplication in a Female Neonate With Trisomy 18",
abstract = "Current guidelines indicate that in patients with developmental disabilities or congenital anomalies, chromosomal microarray (CMA) is a first-tier diagnostic test. However, for patients with obvious chromosomal syndromes such as trisomy 13, 18, and 21, G-banded karyotyping is still recommended over CMA for establishing a diagnosis. In the case presented herein, a female neonate was suspected of having trisomy 18 based on pre- and postnatal evaluations. Karyotyping was requested but not performed due to insufficient cell growth; Interphase fluorescence in situ hybridization (i-FISH) found an extra copy of chromosome 18. CMA analysis uncovered gain of chromosome 18 and an additional duplication in chromosome 22q11.2, which went undetected with FISH. Our patient died within 40 hours after birth, but it is expected that patients with recognizable chromosomal syndromes could benefit from the discovery of coexisting copy number variations (CNVs) using CMA. This case shows that CMA can be a useful test for patients with recognizable chromosomal syndromes because of the potential benefits for patients and their families when co-existing CNVs are found.",
keywords = "22q11.2 duplication syndrome, CNV, copy number variation, trisomy 18, whole genome chromosomal microarray",
author = "Turbiville, {Donald E.} and Hai Wu and Jianli Dong",
year = "2017",
month = "11",
day = "8",
doi = "10.1093/labmed/lmx039",
language = "English (US)",
volume = "48",
pages = "372--375",
journal = "Laboratory Medicine",
issn = "0007-5027",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Detection of an Underlying 22q11.2 Duplication in a Female Neonate With Trisomy 18

AU - Turbiville, Donald E.

AU - Wu, Hai

AU - Dong, Jianli

PY - 2017/11/8

Y1 - 2017/11/8

N2 - Current guidelines indicate that in patients with developmental disabilities or congenital anomalies, chromosomal microarray (CMA) is a first-tier diagnostic test. However, for patients with obvious chromosomal syndromes such as trisomy 13, 18, and 21, G-banded karyotyping is still recommended over CMA for establishing a diagnosis. In the case presented herein, a female neonate was suspected of having trisomy 18 based on pre- and postnatal evaluations. Karyotyping was requested but not performed due to insufficient cell growth; Interphase fluorescence in situ hybridization (i-FISH) found an extra copy of chromosome 18. CMA analysis uncovered gain of chromosome 18 and an additional duplication in chromosome 22q11.2, which went undetected with FISH. Our patient died within 40 hours after birth, but it is expected that patients with recognizable chromosomal syndromes could benefit from the discovery of coexisting copy number variations (CNVs) using CMA. This case shows that CMA can be a useful test for patients with recognizable chromosomal syndromes because of the potential benefits for patients and their families when co-existing CNVs are found.

AB - Current guidelines indicate that in patients with developmental disabilities or congenital anomalies, chromosomal microarray (CMA) is a first-tier diagnostic test. However, for patients with obvious chromosomal syndromes such as trisomy 13, 18, and 21, G-banded karyotyping is still recommended over CMA for establishing a diagnosis. In the case presented herein, a female neonate was suspected of having trisomy 18 based on pre- and postnatal evaluations. Karyotyping was requested but not performed due to insufficient cell growth; Interphase fluorescence in situ hybridization (i-FISH) found an extra copy of chromosome 18. CMA analysis uncovered gain of chromosome 18 and an additional duplication in chromosome 22q11.2, which went undetected with FISH. Our patient died within 40 hours after birth, but it is expected that patients with recognizable chromosomal syndromes could benefit from the discovery of coexisting copy number variations (CNVs) using CMA. This case shows that CMA can be a useful test for patients with recognizable chromosomal syndromes because of the potential benefits for patients and their families when co-existing CNVs are found.

KW - 22q11.2 duplication syndrome

KW - CNV

KW - copy number variation

KW - trisomy 18

KW - whole genome chromosomal microarray

UR - http://www.scopus.com/inward/record.url?scp=85045546454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045546454&partnerID=8YFLogxK

U2 - 10.1093/labmed/lmx039

DO - 10.1093/labmed/lmx039

M3 - Article

VL - 48

SP - 372

EP - 375

JO - Laboratory Medicine

JF - Laboratory Medicine

SN - 0007-5027

IS - 4

ER -